DRIO supply chain intelligence for DarioHealth Corp.: verified suppliers, customers, debt relationships, acquisitions, and ownership data.
Data compiled by Redley Lamar · ChainSifter Intelligence
| Ticker | Name | Confidence | Evidence |
|---|---|---|---|
| A-G-P-ALLIANCE-GLOBAL-PARTNERS | A-G-P-ALLIANCE-GLOBAL-PARTNERS | 92% | The Company may sell Placement Shares to A.G.P. as principal, at a purchase price agreed upon by A.G.P. and the Company. |
| EVERNORTH | EVERNORTH | 85% | Companies such as Teladoc Health, Inc. and MDLive, an Evernorth company, offer a full array of integrated virtual care solutions for primary care, chronic and behavioral health. |
| MDLIVE | MDLIVE | 85% | Companies such as Teladoc Health, Inc. and MDLive, an Evernorth company, offer a full array of integrated virtual care solutions for primary care, chronic and behavioral health. |
| OMADA-HEALTH-INC | OMADA-HEALTH-INC | 85% | Cardiometabolic Health Platforms There are other more narrowly focused companies such as Omada Health, Inc., Vida Health, Inc., |
| TDOC | Teladoc Health, Inc. | 85% | access to users, and the creation of value for users, employers, and health plans. With these two emerging value creation dimensions that are driving competitive advantage, we see the following compa… |
| TDOC | Teladoc Health, Inc. | 85% | Reciprocal relationship from TDOC graph: Reciprocal relationship from DRIO graph: Reciprocal relationship from TDOC graph: Reciprocal relationship from DRIO graph: access to users, and the creation o… |
| VIDA-HEALTH-INC | VIDA-HEALTH-INC | 85% | Cardiometabolic Health Platforms There are other more narrowly focused companies such as Omada Health, Inc., Vida Health, Inc., |
| OMDA | Omada Health, Inc. | 72% | Reciprocal relationship from OMDA graph: Reciprocal relationship from DRIO graph: access to users, and the creation of value for users, employers, and health plans. With these two emerging value crea… |
| OMDA | Omada Health, Inc. | 72% | access to users, and the creation of value for users, employers, and health plans. With these two emerging value creation dimensions that are driving competitive advantage, we see the following compa… |
| SNYNF | Sanofi | 72% | panies are true competitors. Traditional Healthcare Systems and Health Plans While many health systems may have their own home-grown solutions for many of the conditions that we address, few really p… |
| SNYNF | Sanofi | 72% | Reciprocal relationship from SNYNF graph: Reciprocal relationship from DRIO graph: panies are true competitors. Traditional Healthcare Systems and Health Plans While many health systems may have thei… |
| Ticker | Name | Confidence | Evidence |
|---|---|---|---|
| MAJOR-CUSTOMER | MAJOR-CUSTOMER | 92% | As of March 31, 2026 and December 31, 2025, the Company's major customer accounted for 39.5 % and 30.5 %, respectively, of the Company's accounts receivable balance. |
| OMDA | Omada Health, Inc. | 72% | Reciprocal relationship from OMDA graph: Reciprocal relationship from DRIO graph: Reciprocal relationship from OMDA graph: Reciprocal relationship from DRIO graph: access to users, and the creation o… |
| OMDA | Omada Health, Inc. | 72% | access to users, and the creation of value for users, employers, and health plans. With these two emerging value creation dimensions that are driving competitive advantage, we see the following compa… |
| SNYNF | Sanofi | 72% | panies are true competitors. Traditional Healthcare Systems and Health Plans While many health systems may have their own home-grown solutions for many of the conditions that we address, few really p… |
| SNYNF | Sanofi | 72% | Reciprocal relationship from SNYNF graph: Reciprocal relationship from DRIO graph: panies are true competitors. Traditional Healthcare Systems and Health Plans While many health systems may have thei… |
| TDOC | Teladoc Health, Inc. | 72% | Reciprocal relationship from TDOC graph: Reciprocal relationship from DRIO graph: access to users, and the creation of value for users, employers, and health plans. With these two emerging value crea… |
| TDOC | Teladoc Health, Inc. | 72% | access to users, and the creation of value for users, employers, and health plans. With these two emerging value creation dimensions that are driving competitive advantage, we see the following compa… |
| Instrument | Description | Confidence | Evidence |
|---|---|---|---|
| DRIO-DEBT | Debt stack $31.7M | 90% | Market cache reports total debt of $31.7M. |
| DRIO-DEBT-9132 | Xbrl Convertible | 90% | xbrl convertible detail from xbrl 2025-12-31. |
| DRIO-DEBT-9131 | Warrants outstanding: 23483 | 90% | xbrl warrant detail from xbrl 2025-12-31. |
| Holder | Name | Confidence | Evidence |
|---|---|---|---|
| DRIO-OWNER-NANTAHALA-CAPITAL-MANAGEMENT-LLC | Nantahala Capital Management, LLC | 90% | 13F overlay lists Nantahala Capital Management, LLC as top holder; 21 tracked holders. |
| Ticker | Name | Chain Index | Hops | Relationship Types |
|---|---|---|---|---|
| CI | The Cigna Group | 100.00 | 2 | |
| DHIL | Diamond Hill Investment Group Inc | 100.00 | 2 | |
| SNYNF | Sanofi | 100.00 | 1 | ['customer', 'supplier'] |
| TDOC | Teladoc Health, Inc. | 100.00 | 1 | ['customer', 'supplier'] |
| HNGE | Hinge Health, Inc. | 100.00 | 2 | |
| OMDA | Omada Health, Inc. | 100.00 | 1 | ['customer', 'supplier'] |
| ANRO | Alto Neuroscience, Inc. | 50.00 | 2 | |
| ALXO | ALX Oncology Holdings Inc. | 50.00 | 2 | |
| BLRX | BioLineRx Ltd. | 50.00 | 2 | |
| CBIO | Crescent Biopharma, Inc. | 50.00 | 2 | |
| RXRX | Recursion Pharmaceuticals, Inc. | 50.00 | 2 | |
| ANL | Adlai Nortye Ltd. | 50.00 | 2 | |
| CCEP | Coca-Cola Europacific Partners PLC | 50.00 | 2 | |
| DSGN | Design Therapeutics, Inc. | 50.00 | 2 | |
| CYTK | Cytokinetics, Incorporated | 50.00 | 2 | |
| CTMX | CytomX Therapeutics, Inc. | 50.00 | 2 | |
| CLDX | Celldex Therapeutics, Inc. | 50.00 | 2 | |
| AZN | AstraZeneca PLC | 50.00 | 2 | |
| DBVTF | DBV TECHNOLOGIES | 50.00 | 2 | |
| BIOA | BioAge Labs, Inc. | 50.00 | 2 |